Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.51 |
| ▸ | SCN9A | Q15858 | 5/20 | 0.50 |
| ▸ | XIAP | P98170 | 3/20 | 0.50 |
| ▸ | NPY1R | P25929 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18870009 | 0.83 | SCN9A (0.45) | SCN9ANPY1RKMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL6159943 | 0.81 | NPY1R (0.49) | SCN9AXIAPNPY1RKMT2AL3MBTL1 | |
| SCHEMBL4817994 | 0.80 | SCN9A (0.48) | SCN9ANPY1RKMT2AL3MBTL1 | |
| SCHEMBL4816939 | 0.80 | SCN9A (0.48) | SCN9ANPY1RKMT2AL3MBTL1 | |
| SCHEMBL9977203 | 0.80 | SRC (0.49) | SCN9AKMT2AL3MBTL1 | |
| SCHEMBL24379309 | 0.80 | SCN9A (0.48) | SCN9ANPY1RKMT2AL3MBTL1 | |
| SCHEMBL6818187 | 0.78 | GAA (0.50) | ALDH1A1SCN9ANPY1RGAAMAPT | |
| SCHEMBL29048164 | 0.78 | SMN1; SMN2 (0.57) | ALDH1A1SCN9ANPY1RGAAMAPT | |
| SCHEMBL40642 | 0.78 | XIAP (0.60) | ALDH1A1XIAPGAA | |
| SCHEMBL29048158 | 0.77 | ALDH1A1 (0.45) | ALDH1A1GAAMAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170137462-A1 | CATIONIC LIPID CORDIARIMIDE HYBRID COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170137462-A1 | CATIONIC LIPID CORDIARIMIDE HYBRID COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF | CCAR2, LIG3, DCLRE1A | ALDH1A1 1171/4885SCN9A 4658/4885XIAP 289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.